Identification of Candida dubliniensis by thermotolerance test, morphological features and molecular methods;Candida dubliniensis suşlarinin sicaklik toleransi testi̇, morfoloji̇k özelli̇kler ve moleküler yöntemlerle tanimlanmasi

Mikrobiyoloji Bulteni

Volumn 37, Issue 1, 2003, Pages 49-57

  Arikan, Sevtap ^a   Darka, Özge ^a   Hasçelik, Gülşen ^a   Günalp, Ayfer ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Candida albicans; Candida dubliniensis; Polymerase chain reaction

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; ITRACONAZOLE; POLYSORBATE 80;

ANTIBIOTIC SENSITIVITY; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CONFERENCE PAPER; FUNGAL GENETICS; FUNGAL STRAIN; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; FUNGUS SPORE; HEAT TOLERANCE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR GENETICS; MORPHOLOGY; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; SCREENING TEST;

ANTIFUNGAL AGENTS; CANDIDA; CULTURE MEDIA; HEAT; HUMANS; POLYMERASE CHAIN REACTION; POLYSORBATES; SPORES, FUNGAL; SURFACE-ACTIVE AGENTS; ZEA MAYS;

EID: 0038456537     PISSN: 03749096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (39)

1. Krcmery V, Barnes JA: Non-albicans Candida spp. causing fungaemia: Pathogenicity and antifungal resistance. J Hosp Infect 2002, 50: 243-260.
2. Sullivan DJ, Westerneng TJ, Haynes KA, Bennett DE, Coleman DC: Candida dubliniensis sp. nov. phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals. Microbiology 1995, 141: 1507-1521.
3. Boyle BM, Sullivan DJ, Forkin C, Mulcahy F, Keane CT, Coleman DC: Candida dubliniensis candidaemia in an HIV-positive patient in Ireland. Int J Std Aids 2002, 13: 55-57.
4. Polacheck I, Strahilevitz J, Sullivan D, Donnelly S, Salkin IF, Coleman DC: Recovery of Candida dubliniensis from non-human immunodeficiency virus-infected patients in Israel. J Clin Microbiol 2000, 38: 170-174.
5. Odds F, Van Nuffel CL, Dams G: Prevalence of Candida dubliniensis isolates in a yeast stock collection. J Clin Microbiol 1998, 36: 2869-2873.
6. Gales AC, Pfaller MA, Houston AK, et al: Identification of Candida dubliniensis based on temperature and utilization of xylose and alpha-methyl-D-glucoside as determined with the API 20C AUX and vitek YBC systems. J Clin Microbiol 1999, 37: 3804-3808.
7. Pinjon E, Sullivan D, Salkin I, Shanley D, Coleman D: Simple, inexpensive, reliable method for differentiation of Candida dubliniensis from Candida albicans. J Clin Microbiol 1998, 36: 2093-2095.
8. Jabra-Rizk MA, Falkler WA, Merz Jr WG, Baqui A, Kelley JI, Meiller TF: Retrospective identification and characterization of Candida dubliniensis isolates among Candida albicans clinical laboratory isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected individuals. J Clin Microbiol 2000, 38: 2423-2426.
9. Martins-Nishikawa M, Trilles L, Symoens F, Swinne D, Nolard N: Prevalence of Candida dubliniensis in the BCCM/IHEM Biomedical Fungi/Yeasts culture collection (isolates before 1990). Med Mycol 2002, 40: 443-445.
10. Donnelly SM, Sullivan DJ, Shanley DB, Coleman DC: Phylogenetic analysis and rapid identification of Candida dubliniensis based on analysis of ACT1 intron and exon sequences. Microbiology 1999, 145 (Pt 8):1871-1882.
11. Bartie KL, Williams DW, Wilson MJ, Potts AJC, Lewis MAO: PCR fingerprinting of Candida albicans associated with chronic hyperplastic candidosis and other oral conditions. J Clin Microbiol 2001, 39: 4066-4075.
12. Kurzai O, Heinz WJ, Sullivan DJ, Coleman DC, Frosch M, Muhlschegel FA: Rapid PCR test for discriminating between Candida albicans and Candida dubliniensis isolates using primers derived from the pH-regulated PHR1 and PHR2 genes of C.albicans. J Clin Microbiol 1999, 37: 1587-1590.
13. Staib F, Arasteh K: Chlamydospore formation on Staib agar. Observations made before Candida dubliniensis was described. Mycoses 2001, 44: 23-27.
14. Alves SH, Milan EP, Sant'Ana PD, Oliveira LO, Santurio JM, Colombo AL: Hypertonic Sabouraud broth as a simple and powerful test for Candida dubliniensis screening. Diagn Microbiol Infect Dis 2002, 43: 85-86.
15. Kirkpatrick WR, Revankar SG, McAtee RK, et al: Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar Candida screening and susceptibility testing of isolates. J Clin Microbiol 1998, 36: 3007-3012.
16. Jabra-Rizk MA, Falkler WA, Merz Jr WG, Kelley JI, Baqui A, Meiller TF: Coaggregation of Candida dubliniensis with Fusobacterium nucleatum. J Clin Microbiol 1999, 37: 1464-1468.
17. Mahmoudabadi AZ, Radcliffe CE, Coleman DC, Drucker DB: Comparison of Candida dubliniensis and C.albicans based on polar lipid composition. J Appl Microbiol 2002, 93: 894-899.
18. Peltroche-Uacsahuanga H, Schmidt S, Seibold M, Lutticken R, Haase G: Differentiation between Candida dubliniensis and Candida albicans by fatty acid methyl ester analysis using gas-liquid chromatography. J Clin Microbiol 2000, 38: 3696-3704.
19. Bikandi J, San Millan R, Moragues MD, et al: Rapid identification of Candida dubliniensis by indirect immunofluorescence based on differential localization of antigens on C.dubliniensis blastospores and Candida albicans germ tubes. J Clin Microbiol 1998, 36: 2428-2433.
20. Larone DH: Medically important fungi. A guide to identification. 1993. ASM Press, Washington, DC.
21. Burik VJA, Myerson D, Schreckhise WR, Bowden AR: Panfungal PCR assay for detection of fungal infection in human blood specimens. J Clin Microbiol 1998, 36: 1169-1175.
22. National Committee for Clinical Laboratory Standards: Reference Method for Broth Dilution Antifugal Susceptibility Testing of Yeasts. 2002, 2nd ed. Approved Standard M27-A2. NCCLS, Wayne, Pa.
23. Milan EP, Sant'Ana PD, Melo ASD et al: Multicenter prospective surveillance of oral Candida dubliniensis among adult Brazilian human immunodeficiency virus-positive and AIDS patients. Diagn Microbiol Infect Dis 2001, 41: 29-35.
24. Çetinkaya Z, Kurutepe S, Özbakkaloǧlu B, Deǧerli K, Sürücüoǧlu S: Candida albicans suşlarinin Candida dubliniensis yönünden deǧeriendirilmesi. Candida Mikrobiyolojisi ve İnfeksiyonlari Sempozyumu, 21-22 Haziran 2002, Eskişehir. Kongre Kitabi, s: 198.
25. Hilmioǧlu S, Aydemir Ş, Inci R, Gürel SÖ, Tümbay E: Candida albicans kökenlerinin Candida dubliniensis için yeniden deǧerlendirilmesi. 1. Ulusal Mantar Hastaliklari ve Klinik Mikoloji Kongresi, 4-6 Mayis 1999, İzmir. Kongre Kitabi, s: 265.
26. Karaca N, Eşel D, Koç NA: Çeşitli klinik örneklerden izole edilen Candida albicans kökenlerinin Candida dubliniensis yününden deǧerlendirilmesi. 2.Ulusal Mantar Hastaliklari ve Klinik Mikoloji Kongresi, 19-21 Haziran 2001, Ankara. Kongre Kitabi, s: 246.
27. Yücel A, Kantarcioǧlu SA: Candida albicans kökenlerinin kaç tanesi Candida dubliniensis? 1.Ulusal Mantar Hastaliklari ve Klinik Mikoloji Kongresi, 4-6 Mayis 1999, İzmir. Kongre Kitabi, s: 263.
28. Esen N, Şengönül A, Yuluǧ N: Rutin laboratuvarda Candida albicans tanisi almiş izolatlarda üç farkli yöntemle Candida dubliniensis araştirilmasi. 29.Türk Mikrobiyoloji Kongresi, 8-13 Ekim 2000, Antalya, Kongre Kitabi, s: 326.
29. Tekeli A, Dolapçi I, Emral R, Cesur S: İnsülin kullanan Diabetes Mellitus'lu hastalarin orofarengial örneklerinde Candida taşiyiciliǧi ve Candida dubliniensis araştirilmasi. 30.Türk Mikrobiyoloji Kongresi, 30 Eylül- 5 Ekim 2002, Antalya. Kongre Kitabi, s: 315.
30. Tekeli A, Dolapçi I, Cesur S, Tekeli E, Içli F: Onkoloji hastalarinin orofaringeal örneklerinde Candida dubliniensis araştirilmasi ve izole edilen Candida suşlarinin tiplendirilmesi. Mikrobiyoloji Bült 2002, 36: 57-63.
31. Dolapci I, Tekeli A, Gocmen JS, Aysev D, Guriz H: Investigation of Candida dubliniensis in Candida spp.-positive hemocultures. Apmis 2002, 110: 391-395.
32. Bozdayi G, Kalkanci A, Birl A, Kuştimur S: Çeşitli örneklerden izole edilen ve ID32 C kiti ile Candida albicans olarak isimlendirilen suşlarin PCR ve klasik yöntemler ile yeniden tiplendirilmesi. 2.Ulusal Mantar Hastaliklari ve Klinik Mikoloji Kongresi, 19-21 Haziran 2001, Ankara. Kongre Kitabi, s: 193.
33. Kömeç S, Öǧüdücü D, Yeǧenoǧlu Y: Candida albicans' lanmiz arasinda Candida dubliniensis var mi? 29.Türk Mikrobiyoloji Kongresi, 8-13 Ekim 2000 Antalya. Kongre Kitabi, s: 362.
34. Martinez M, Lopez-Ribot JL, Kirkpatrick WR, Coco BJ, Bachmann SP, Patterson TF: Replacement of Candida albicans with C dubliniensis in human immunodeficiency virus-infected patients with oropharyngeal candidiasis treated with fluconazole. J Clin Microbiol 2002, 40: 3135-3139.
35. Ruhnke M, Schmidt-Westhausen A, Morschhauser J: Development of simultaneous resistance to fluconazole in Candida albicans and Candida dubliniensis in a patient with AIDS. J Antimicrob Chemother 2000, 46: 291-295.
36. Pfaller MA, Messer SA, Gee S, et al: In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agents. J Clin Microbiol 1999, 37: 870-872.
37. Quindos G, Carrillo-Munoz AJ, Arevalo MP, et al: In vitro susceptibility of Candida dubliniensis to current and new antifungal agents. Chemotherapy 2000, 46: 395-401.
38. Sebti A, Kiehn TE, Perlin D, et al: Candida dubliniensis at a cancer center. Clin Infect Dis 2001, 32: 1034-1038.
39. Hilmioǧlu S, Aydemir Ş, Gürel Ö, Inci R, Tümbay E: The first four isolates of Candida dubliniensis in Turkey and their invitro susceptibility to amphotericin B, fluconazole and itraconazole. A preliminary study. European Society of Chemotherapy, 6th Scientific Meeting. May 20-22 1999, Istanbul. Abstract Book p: 74.